Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
- PMID: 32554538
- PMCID: PMC7301835
- DOI: 10.1183/13993003.01634-2020
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
Abstract
Endothelial cell dysfunction and impaired microcirculatory function contribute markedly to life-threatening complications of COVID-19, such as venous thromboembolic disease and multiple organ involvement
Conflict of interest statement
Conflict of interest: A. Huertas has nothing to disclose. Conflict of interest: D. Montani reports grants and personal fees from Actelion and Bayer, personal fees from GSK, Pfizer, Chiesi and Boehringer, grants, personal fees and non-financial support from MSD, non-financial support from Acceleron, outside the submitted work. Conflict of interest: L. Savale reports personal fees and non-financial support from Actelion and Bayer, grants and personal fees from GSK, outside the submitted work. Conflict of interest: J. Pichon has nothing to disclose. Conflict of interest: L. Tu has nothing to disclose. Conflict of interest: F. Parent reports grants from Bayer, CSL Behring and Sanofi, outside the submitted work. Conflict of interest: C. Guignabert has nothing to disclose. Conflict of interest: M. Humbert reports grants and personal fees from Actelion, Bayer, GSK and Acceleron, personal fees from Merck and United Therapeutics, outside the submitted work.
Figures

Comment in
-
Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?Eur Respir J. 2020 Oct 15;56(4):2003167. doi: 10.1183/13993003.03167-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32859681 Free PMC article.
Comment on
-
Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?Eur Respir J. 2020 Jul 30;56(1):2001201. doi: 10.1183/13993003.01201-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32398294 Free PMC article.
-
Pulmonary embolism in patients with COVID-19 pneumonia.Eur Respir J. 2020 Jul 30;56(1):2001365. doi: 10.1183/13993003.01365-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32398297 Free PMC article.
Similar articles
-
Thrombosis and COVID-19 pneumonia: the clot thickens!Eur Respir J. 2020 Jul 30;56(1):2001608. doi: 10.1183/13993003.01608-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32554532 Free PMC article.
-
Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients.Thromb Res. 2020 Jun;190:102. doi: 10.1016/j.thromres.2020.04.021. Epub 2020 Apr 21. Thromb Res. 2020. PMID: 32335420 Free PMC article. No abstract available.
-
Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?Am J Respir Crit Care Med. 2020 Aug 1;202(3):455-457. doi: 10.1164/rccm.202005-1654LE. Am J Respir Crit Care Med. 2020. PMID: 32510975 Free PMC article. No abstract available.
-
[Ophthalmological care of SARS-CoV-2 positive patients in intensive care units].Ophthalmologe. 2020 Jul;117(7):602-608. doi: 10.1007/s00347-020-01159-6. Ophthalmologe. 2020. PMID: 32617666 Free PMC article. Review. German.
-
Risk of venous thromboembolism in users of contraception and menopausal hormone therapy during the COVID-19 pandemic.Rev Assoc Med Bras (1992). 2020 Sep 21;66Suppl 2(Suppl 2):22-26. doi: 10.1590/1806-9282.66.S2.22. eCollection 2020. Rev Assoc Med Bras (1992). 2020. PMID: 32965350 Review.
Cited by
-
Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review.Infection. 2023 Dec;51(6):1603-1618. doi: 10.1007/s15010-023-02017-8. Epub 2023 Mar 12. Infection. 2023. PMID: 36906872 Free PMC article. Review.
-
The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study.Front Pharmacol. 2022 Jul 5;13:742273. doi: 10.3389/fphar.2022.742273. eCollection 2022. Front Pharmacol. 2022. PMID: 35865966 Free PMC article.
-
Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.Fluids Barriers CNS. 2022 Aug 18;19(1):63. doi: 10.1186/s12987-022-00357-5. Fluids Barriers CNS. 2022. PMID: 35982454 Free PMC article. Review.
-
Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail.Inflamm Res. 2022 Nov;71(10-11):1159-1167. doi: 10.1007/s00011-022-01615-w. Epub 2022 Aug 8. Inflamm Res. 2022. PMID: 35941297 Free PMC article. Review.
-
Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.Br J Pharmacol. 2022 May;179(10):2086-2099. doi: 10.1111/bph.15587. Epub 2021 Jul 7. Br J Pharmacol. 2022. PMID: 34235728 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous